Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasAddiction psychiatry — dual diagnosis and integrated care

Psych Vivas · Addiction psychiatry — dual diagnosis and integrated care

Dual diagnosis and integrated care — structured clinical viva

Fellowship viva on dual diagnosis: sequential vs integrated care, MI, stages of change, comorbidity models, systems design, recovery.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar. A community team refuses to accept a 32-year-old woman with bipolar disorder and alcohol dependence until she completes residential detox and 4 weeks abstinence. She is ambivalent about alcohol, depressed, and at elevated suicide risk. Discuss definition, care models, stages of change, MI, etiological models, integrated management, systems barriers, NICE/RANZCP-style principles, recovery, and evidence limits.

Interpretation

Reveal interpretation

Problem diagnosis. This is sequential gatekeeping: mental health contingent on prolonged abstinence. It is the classic systems failure dual-diagnosis literature exists to correct.[1]

Definition. Co-occurring bipolar disorder and alcohol use disorder — both primary concurrent problems.[1]

Models. Prefer integrated concurrent care; parallel only if tightly coordinated; reject sequential default.[1]

Stage. Ambivalence ≈ contemplation — ideal MI territory (explore pros/cons, discrepancy, plan when ready for action).[3]

Safety. Suicide risk elevated in dual mood + alcohol — same-day safety plan, means restriction, senior review; medical withdrawal risk if she stops alcohol abruptly.[1]

Etiology. Bidirectional common: alcohol worsens mood stability; depression/mania increases drinking. Name Mueser models.[2]

Plan. Mood stabiliser pathway as indicated for bipolar; alcohol pharmacotherapy candidates (e.g. naltrexone/acamprosate after medical review); MI; family; shared dual plan ending bounce; housing/work; peer supports. Recovery multi-domain; long-term integrated care can improve outcomes (NH dual diagnosis longevity data in SMI+SUD populations).[1][4]

Evidence honesty. Cochrane psychosocial dual packages show limited clear superiority over standard care in RCTs — still integrate; do not use as nihilism licence.[5]

Guideline principles. NICE/RANZCP-style: assess both domains, do not exclude, coordinate concurrent care, physical health, family.[1]

Key points

Integrated concurrent care

Do not make bipolar treatment wait on 4 weeks dry time.

Stage-match MI

Ambivalence is a clinical target, not a reason for rejection.

Safety first

Suicide and withdrawal risk ride with dual mood–alcohol presentations.
[1] [3]

References

  1. [1]Drake RE, Mueser KT, Brunette MF Management of persons with co-occurring severe mental illness and substance use disorder: program implications World Psychiatry, 2007.PMID 18188429
  2. [2]Mueser KT, Drake RE, Wallach MA Dual diagnosis: a review of etiological theories Addict Behav, 1998.PMID 9801712
  3. [3]Hettema J, Steele J, Miller WR Motivational interviewing Annu Rev Clin Psychol, 2005.PMID 17716083
  4. [4]Drake RE, McHugo GJ, Xie H, et al. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders Schizophr Bull, 2006.PMID 16525088
  5. [5]Hunt GE, Siegfried N, Morley K, et al. Psychosocial interventions for people with both severe mental illness and substance misuse Cochrane Database Syst Rev, 2019.PMID 31829430